Conference Call and Webcast August 11 at 8:00 am Eastern Time / 7:00 am Central Time Company Confident in Plan to Resolve Issues that Led to Clinical Hold of Phase 2/3 ReMEDy2 Trial Proposal to Resume Trial Will be Submitted to FDA in September Cash Runway Into 2024 MINNEAPOLIS–(BUSINESS WIRE)–DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a … [Read more…]
Michael Smith to retire after 5 years of service; Jeff Schwaneke named to agilon board AUSTIN, Texas–(BUSINESS WIRE)–agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that Michael Smith will retire from agilon health’s board of directors after more than five years of service. Upon … [Read more…]
– Completed positive End-of-Phase 2 meeting with the Food and Drug Administration (“FDA”) and received scientific advice from the European Medicines Agency (“EMA”) to support design of its CALM Phase 3 program, which is expected to initiate in Q4 2022 – – Ended second quarter 2022 with approximately US$384.6 million in pro-forma cash, cash equivalents … [Read more…]
– Efficacy Observed with QINLOCK® was Comparable to Sunitinib with a More Favorable Safety and Tolerability Profile in GIST Patients Previously Treated with Imatinib – WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that … [Read more…]
WASHINGTON–(BUSINESS WIRE)–The Partnership for Safe Medicines, a public health group committed to the safety of pharmaceutical medicines, applauds the International Criminal Police Organization (INTERPOL) for organizing the seizure of over $11 million in counterfeit medicines during Operation Pangea XV, an initiative to combat the global trafficking of counterfeit pharmaceuticals marketed and sold online. During the … [Read more…]
Regulatory Clarity Enables ZIVO to Focus and Optimize Development Strategy BLOOMFIELD HILLS, Mich.–(BUSINESS WIRE)–ZIVO Bioscience, Inc. (NASDAQ: ZIVO) (the “Company”), a biotech/agtech R&D company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, announces receipt of a letter from the U.S. Department of Agriculture’s (USDA) Center for Veterinary … [Read more…]
New CEO Brings Strong Track Record of Passion for Growth and Innovation in the Medical Device and Healthcare Sectors MINNEAPOLIS–(BUSINESS WIRE)–Nonin Medical today announced that its board of directors has appointed healthcare industry veteran John M. Hastings as its new Chief Executive Officer, effective August 29, 2022. Hastings brings global leadership and technical expertise in … [Read more…]
Funds will be used to address urgent needs and long-term rebuilding efforts LOUISVILLE, Ky.–(BUSINESS WIRE)–UnitedHealthcare and Optum, part of UnitedHealth Group (NYSE: UNH), announced today a $205,000 donation to help eastern Kentucky residents following the devastating flooding that impacted local communities. The funds will support immediate needs, as well as longer-term recovery and rebuilding efforts, … [Read more…]
Cerene Cryotherapy is clinically proven to significantly reduce menstrual bleeding and premenstrual symptoms safely and effectively with high patient satisfaction through 36 months following treatment BERKELEY, Calif.–(BUSINESS WIRE)–Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced the publication of long-term clinical … [Read more…]
PALM DESERT, Calif.–(BUSINESS WIRE)–Amputee Coalition 2022 National Conference comes to Palm Desert at the JW Marriott Desert Springs Resort & Spa welcoming over 650 attendees. Paralympic Silver Medal Combat Veteran and Amputee, John Register has been appointed Interim President and CEO of the Amputee Coalition. John Register will lead the organization to convene its 2022 … [Read more…]
